Search Results 1501-1510 of 16414 for alt

  1. Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary - Mayo Clinic

    Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) ≤ 2.5 X ULN OR ≤ 5 X ULN for subjects with liver metastases; Albumin > 2.5 g/dL; Females ...

  2. Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia - Mayo Clinic

    ... (ALT) < 3 x upper limit of normal (ULN); RANDOMIZATION TO BLINATUMOMAB OR NO BLINATUMOMAB-STEP 3; Patients must have an ECOG performance status of 0-2; Patients ...

  3. A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis - Mayo Clinic

    Alanine aminotransferase level (ALT) ≤2.5 times the ULN;; Aspartate aminotransferase (AST) ≤2.5 times the ULN;; Total bilirubin level ≤1.5 × ULN except for ...

  4. Efficacy, Safety, And Tolerability Study Of Lunsekimig Compared With Placebo In Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized By An Eosinophilic Phenotype PERSEPHONE - Mayo Clinic

    Clinically significant laboratory tests at Screening (Visit 1): Alanine transaminase (ALT) or aspartate aminotransferase (AST) >2 times upper limit of normal ( ...

  5. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

    Aspartate aminotransferase (AST) and alanine aminotransaminase (ALT) must be ≤ 2.5 x ULN for the lab or ≤ 5 x ULN for patients with liver metastases (within ...

  6. A Study Of 177Lu-FAP-2286 In Advanced Solid Tumors - Mayo Clinic

    Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 × institutional upper limit of normal (ULN); if liver metastases, then ≤ 5 × the ...

  7. Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for Locally Advanced or Metastatic ER+/HER2− Breast Cancer - Mayo Clinic

    ALT and AST levels::S3 upper limit of normal (ULN) or ::S5 in the presence of liver metastasis;; Total serum bilirubin ::Sl .5 X ULN (::S3 X ULN for subjects ...

  8. A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis - Mayo Clinic

    AST or ALT > 2.5 x ULN;; Amylase or lipase > 2 x ULN;; Neutrophils < 1.5 x10^3 /µL;; Positive hepatitis B surface antigen (HBsAg);; Patients who are HBsAg ...

  9. Phase 2a Open-Label Pilot Study Of VTX2735 In Recurrent Pericarditis - Mayo Clinic

    AST or ALT ≥ 2.0 × ULN; Total bilirubin level > 1.5 × ULN unless the participant has been diagnosed with Gilberts' disease and this is clearly documented ...

  10. Phase 1 Study of Oral TP-1454 - Clinical Trials

    Aspartate aminotransferase (AST/SGOT), alanine aminotransferase (ALT/SGPT) and alkaline phosphatase ≤ 2.5 x ULN* *If liver metastases are present, then ≤ 3 x ...